The agency said its goal is to make it easier to screen people returning to work and school.
“We believe this effort will pave the way for further expanding the availability of tests authorized for screening asymptomatic individuals, help bolster existing and new testing programs and increase consumer access to testing,” Jeff Shuren, MD, director of the FDA’s Center for Devices and Radiological Health, and Tim Stenzel, MD, PhD, director of the Office of In Vitro Diagnostics, said in a news release.
Some rapid tests are less accurate in asymptomatic people, Politico reported. But the FDA’s updated policy takes into account that repeated testing for screening purposes can improve the overall accuracy of test results.
The FDA said it will allow companies to apply to market over-the-counter tests for at-home or point-of-care use if they can provide evidence the test performs well in people with symptoms of COVID-19 and that repeated testing can help mitigate false results.
Read the FDA’s full news release here.
More articles on supply chain:
FDA warns of false positives from Roche’s combo flu, COVID-19 test
Mississippi hospital still faces price-gouging, PPE shortages, supply chain director says
Cardinal Health to sell Cordis medical device business for $1B
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
